Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Biomedical Advanced Research & Development Authority (BARDA)

Biomedical Advanced Research & Development Authority (BARDA) Newsletter

NIAID Research Key to H5N1 Influenza Preparedness Efforts 26 Dec 2024 19:22 GMT
… of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) is responsible for …
Opinion: Prepare now to use convalescent plasma for the next pandemic 26 Dec 2024 13:24 GMT
… the U.S., the Biomedical Advanced Research and Development Authority worked with and funded the …
Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics 26 Dec 2024 06:53 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; Antibacterials branch; under agreement …
Basilea receives additional funding from CARB-X to advance antibiotic candidate 24 Dec 2024 13:03 GMT
… Health and Human Services (HHS); Biomedical Advanced Research and Development Authority; Antibacterials branch; Administration for …
Acute Respiratory Distress Syndrome Pipeline And Clinical Trials Assessment 2024: FDA Approvals, Therapies And Key Companies Involved By Delveinsight | RS Biotherapeutics, AVM Biotech, Cynata Therapeu 24 Dec 2024 01:52 GMT
… , has been chosen by the Biomedical Advanced Research and Development Authority (BARDA) to conduct the …
36 chief innovation officers to know | 2024 24 Dec 2024 00:46 GMT
… 10-year, $15 million Biomedical Advanced Research and Development Authority contract with a $515 million …
Federal Bill Reintroduced to Strengthen Pharmaceutical Supply Chain 23 Dec 2024 21:04 GMT
… will be allocated to the Biomedical Advanced Research and Development Authority annually for the next …
Gangagen Secures Additional US$7.9 Million From CARB-X For Pre-Clinical Development Of Novel Klebicins Targeting Nosocomial Pneumonia Caused By Multidrug-Resistant Klebsiella Pneumoniae Media Outreach Newswire APAC 23 Dec 2024 10:48 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028 …
Basilea Is Awarded Additional CARB-X Funding To Develop New Drug Candidate From A Novel Class Of Antibiotics 23 Dec 2024 06:48 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; Antibacterials branch; under agreement …
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics 23 Dec 2024 06:15 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; Antibacterials branch; under agreement …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS